Abstract: This rotor manufacturing method includes the steps of: pressing a rotor core in a central axis direction by using a core pressing member; and fixing a shaft to the rotor core by performing, with the rotor core pressed, hydroforming that involves pressure-welding the shaft to an inner peripheral surface of a shaft insertion hole.

Abstract: An automatic adjustment circuit for amplitude of differential signal has a differential signal transceiver that transmits differential signals, an amplitude setting register in which plural setting values for setting amplitude of the differential signals are stored, an amplitude control circuit that controls the amplitude of the differential signals, a pattern generating circuit that outputs a test pattern, a multiplexer, a squelch detection receiver, a test loop-back circuit, a squelch-signal-change-detection expected-value memory that stores an expected value of a change in a squelch signal, a squelch-signal-change detection counter that counts the change in the squelch signal, a comparator that compares the expected value and a count value and outputs a difference value of the values, a comparison result memory that stores the difference value, and a controller.

Abstract: A bus interface unit receives first and second data sent out to a data bus and observes address values indicated on an address bus. The first and second data are written into first and second registers respectively. First and second address detection unit receive the address values observed by the bus interface respectively. The first address detection unit outputs a first detection signal when it detects an address value which corresponds with the value of the first data. The second address detection unit outputs a second detection signal, when it detects an address value having an increment from the first data, which corresponds with the value of the second data. A control unit raises the priority of one of the bus masters given a bus utilization right, during the period from a start of outputting the first detection signal to an end of outputting the second detection signal.

Abstract: An automatic adjustment circuit for amplitude of differential signal has a differential signal transceiver that transmits differential signals, an amplitude setting register in which plural setting values for setting amplitude of the differential signals are stored, an amplitude control circuit that controls the amplitude of the differential signals, a pattern generating circuit that outputs a test pattern, a multiplexer, a squelch detection receiver, a test loop-back circuit, a squelch-signal-change-detection expected-value memory that stores an expected value of a change in a squelch signal, a squelch-signal-change detection counter that counts the change in the squelch signal, a comparator that compares the expected value and a count value and outputs a difference value of the values, a comparison result memory that stores the difference value, and a controller.

Abstract: A receiver provides a differential signal of first and second signals as received serial data. A tracking circuit receives the received serial data and a clock signal to generate a synchronous clock signal based on the clock signal by tracking the received serial data. Then the tracking circuit generates a synchronous serial data synchronized with the synchronous clock signal. An idle detector receives the first signal and the second signal. Then the idle detector detects an idle period of the first and second signals to provide an idle signal. A memory stores the serial data in response to transitions in the synchronous clock signal. The memory provides the stored data in response to transitions in the clock signal. The memory stops storing based on a hold signal. A data protector generates the hold signal to provide the hold signal for the memory.

Abstract: A differential receiver provides a differential signal of the first and second signals as received serial data. A tracking circuit receives the received serial data and the clock signal to generate a synchronous clock signal based on the clock signal by tracking the received serial data. Then the tracking circuit generates a synchronous serial data synchronized with the synchronous clock signal. An idle detector receives the first signal and the second signal. Then the idle detector detects an idle period of the first and second signals to provide an idle signal. A memory stores the serial data in response to transitions in the synchronous clock signal. The memory provides the stored data in response to transitions in the clock signal. The memory stops storing based on a hold signal. A data protector generates the hold signal to provide the hold signal for the memory.

Abstract: The present invention relates to an optically active, substituted phenylalkylamine derivative represented by Formula [1]: ##STR1## wherein A is a substituted or non-substituted phenyl or thienyl; X.sup.1 is hydrogen, halogen, hydroxyl or a substituted or non-substituted C.sub.1-5 alkoxy; R.sup.1 and R.sup.2 are equally or differently hydrogen, C.sub.1-7 alkyl, C.sub.3-7 alkenyl or C.sub.3-7 alkynyl; R.sup.3 is C.sub.1-10 alkyl, C.sub.2-10 alkenyl or C.sub.2-10 alkynyl; n is an integer from 2 to 5; and m is an integer from 1 to 4,or a pharmaceutically acceptable salt thereof, and pharmaceutical use of such compound or salt. The compound of the invention is excellent in sigma 1 receptor antagonism and useful for treating schizophrenia, depression, anxiety, cerebrovascular diseases/senile troublesome behaviors, and cognitive dysfunctions and motor dysfunctions such as Alzheimer's disease, Parkinson's disease and Huntington's disease which are neurodegenerative diseases.

Abstract: Object: To provide compounds useful as inhibitors of blood platelet aggregation for intravenous administration.Constitution: A thiazoline derivative represented by the formula: ##STR1## ?wherein R.sup.1 is a hydroxyl group, an alkoxy group, a cycloalkoxy group or a group represented by the formula: R.sup.4 NH-- (wherein R.sup.4 is a cycloalkyl group), R.sup.2 is an alkyl group, a cycloalkyl group or a phenylalkyl group, R.sup.3 is a hydrogen atom or an alkyl group, and n is an integer of 2 to 9! or a salt thereof.

Abstract: Object: To provide an antipsychotic drug being different in functional mechanism from dopamine autoreceptor agonists, namely, to provide an antipsychotic drug having a specific affinity for a sigma receptor and causing no extrapyramidal disorder.Constitution: An aminoalkylthiazole derivative represented by formula: ##STR1## (wherein R.sup.1 represents a phenyl group substituted with a halogen atom; R.sup.2 and R.sup.3 are either the same or different and each represents an alkyl group having 4 to 10 carbon atoms; and n is 2 or 3;) and a salt thereof.

Abstract: 2-nitroxyethyl (+)apovincaminate is used as an agent for relieving disturbance of consciousness and as a narcotic antagonist.

Abstract: An alkoxyphenylalkylamine derivative represented by the following formula: ##STR1## (wherein X.sup.1 and X.sup.2 may be either the same or different from each other and each represents a hydrogen atom, a halogen atom, a hydroxyl group, an alkoxy group having 1 to 5 carbon atoms or an alkoxy group having 1 to 5 carbon atoms and substituted with a phenyl group; R.sup.1 and R.sup.2 may be either the same or different from each other and each represents a hydrogen atom, an alkyl group having 1 to 7 carbon atoms, an alkyl group having 1 to 7 carbon atoms and substituted with "a hydroxyl group, a carboxyl group or an alkoxycarbonyl group" at the end, or, R.sup.1 and R.sup.

Abstract: A thiazoline derivative represented by the formula: ##STR1## [wherein R.sup.1 is cyano, carbamoyl, thiocarbamoyl, morpholinothiocarbonyl, alkylthioimidoyl, amidino, substituted amidino or imidazolin-2-yl, R.sup.2 is alkyl or aralkyl, R.sup.3 is hydrogen or alkyl, R.sup.4 is hydroxyl, alkoxy, substituted alkoxy or amino, l is an integer of 1 to 5] and salts thereof have fibrinogen receptor antagonism and cell adhesion factor antagonism, and are useful as therapeutic agents for ischemic diseases and atherosclerosis diseases, and metastasis inhibitory agents of tumors.

Abstract: An anilide derivative useful as an atherosclerosis treating drug, represented by the following formula (I): ##STR1## wherein X is an alkyl group having 1 to 4 carbon atoms or an alkoxy group having 1 to 4 carbon atoms; Y is a hydrogen atom or an alkoxy group having 1 to 4 carbon atoms; Z is an alkyl group having 1 to 4 carbon atoms or an alkoxy group having 1 to 4 carbon atoms; A is an alkylene group having 1 to 4 carbon atoms; R is an alkyl group having 6 to 20 carbon atoms, an alkanoyl group having 2 to 20 carbon atoms or a benzyl group which may be substituted with an alkyl group having 1 to 4 carbon atoms; and n is 0, 1 or 2.

Abstract: An anilide compound represented by formula (I): ##STR1## wherein R.sup.1 and R.sup.2, which may be the same or different, each represent an alkyl group having 1 to 4 carbon atoms; n represents 0, 1 or 2; A represents an alkylene group having 1 to 14 carbon atoms or a group represented by --CH.sub.2 CO--; and Ar represents a phenyl group, a phenyl group substituted with a halogen atom, a nitro group, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, an alkanoyl group having 2 to 5 carbon atoms or a trifluoromethyl group, a benzyl group, a pyridyl group, a pyridyl group substituted with a halogen atom or a trifluoromethyl group, or a pyrimidyl group, or a salt thereof. The disclosed anilide compounds have potent ACAT inhibitory activity.

Abstract: A sulfonamide derivative represented by the Formula: ##STR1## wherein A, B, X, Y, R, m and n are as defined in the specification, and a salt thereof have thromboxane A.sub.2 antagonism, therefore they are useful, for example, as blood platelet aggregation inhibiting agents.

Abstract: Carbazole compounds represented by the formula ##STR1## wherein R.sup.1 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, R.sup.2 is a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, an alkanoyl group having 2 to 6 carbon atoms or a benzoyl group, R.sup.3 and R.sup.4 are the same or different, and are each hydrogen atom, an alkyl group having 1 to 7 carbon atoms, an alkenyl group having 2 to 4 carbon atoms, an alkyl group having 1 to 3 carbon atoms substituted by a phenyl group, or R.sup.3 and R.sup.4 together with the nitrogen atom to which they are attached form a morpholino group, a piperidino group, a pyrrolidino group or a piperazino group, and n is an integer from 1 to 3, and salts thereof have strong antipsychotic activity.

Abstract: A triazole derivative represented by the formula ##STR1## wherein R.sup.1 is a hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms, an acetyl group, a naphthylmethyl group, an anthrylmethyl group or a group of the formula ##STR2## wherein X, Y and Z are the same or different and each a hydrogen atom, a halogen atom, a lower alkyl group having 1 to 4 carbon atoms, a lower alkoxy group having 1 to 4 carbon atoms, a hydroxyl group, a nitro group, a trifluoromethyl group, a cyano group or a benzyloxy group, and R.sup.2 is a hydrogen atom or an acetyl group, and R.sup.3 is a hydrogen atom, an acetyl group or a group of the formula ##STR3## wherein R.sup.1 and R.sup.2 are as defined above, are useful as the inhibitors of lipid peroxidation.

Abstract: A 2-azetizinone derivative represented by the formula: ##STR1## wherein R.sup.1 is a halogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms or an alkoxycarbonyl group in which the alkoxy group has 1 to 4 carbon atoms, R.sup.2 is a group represented by the formula ##STR2## a pyrrolidinyl group or a tetrahydroazepinyl group, and n is an integer of from 2 to 10, and a salt thereof are disclosed. These compounds are useful as blood platelet aggregation inhibiting agent.

Abstract: In a fuel supply device for vehicles, a sub-tank is arranged within a fuel tank. At least one intake port is provided in a bottom wall of the sub-tank. A check valve is arranged at the intake port. A fuel pump is arranged within the sub-tank to supply fuel from the sub-tank to an engine. A fuel return pipe is provided through which a part of the fuel supplied through the fuel supply pipe is returned into the sub-tank. A jet pump is connected to the fuel return pipe so as to deliver the fuel within the fuel tank into the sub-tank through at least one suction port of the jet pump by using fluid energy of the fuel returned into the sub-tank. A pipe is connected to a fuel discharge port of the jet pump, and extends to an upper location within the sub-tank. The jet pump is constituted by a groove forming a flat fluid control device arranged between the fuel pump and the bottom wall of the sub-tank. The groove is formed therein with the fuel suction port and the fuel discharge port of the jet pump.

Abstract: 2-Azetidione derivatives represented by the following formula ##STR1## wherein X is a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a hydroxyl group or a cyano group, l is 1 or 2, R.sup.1 is a lower alkyl group, a cycloalkyl group, a 1-naphthylmethyl group, an optionally substituted phenethyl group, an optionally substituted phenyl group, an optionally substituted benzyl group or a bis(alkoxycarbonyl)ethyl group, and R.sup.2 is a lower alkyl group, a lower alkoxy group, an amino group, an adamantyl group, a lower alkoxycarbonylmethyl group or an optionally substituted phenyl group, are disclosed. These compounds are useful as blood platelet aggregation inhibiting agents.